期刊文献+

脉君安片主要降压成分葛根素和氢氯噻嗪在大鼠体内的药动学研究 被引量:3

Pharmacokinetics of puerarin and hydrochlorothiazide from Maijunan tablets in rats
原文传递
导出
摘要 脉君安片是由葛根、氢氯噻嗪和钩藤三味药组成的复方制剂,临床用于高血压、冠心病等有较好的疗效。葛根素是葛根中的主要黄酮类化合物,对心脑血管疾病有显著的治疗作用[1]。氢氯噻嗪为中效利尿剂,它通过抑制肾小管对钠和水的再吸收,从而达到降压作用。 After oral administration of low, middle, high dose of simulative Maijunan tablets to SD rats and puerarin, hydrochlorothiazide at middle dosage to SD rats separately, plasma samples were collected at different times and treated with acetonitrile to precipitate protein. The contents of puerarin and hydrochlorothiazide in plasma were determined by HPLC method. The mean plasma concentration-time profiles of puerarin and hydrochlorothiazide at different dosages of medication administration were processed by 3P97 pharmacokinetic software and SPSS statistics 17.0 software. The results indicated that the in vivo kinetic processes of puerarin in rats were all fitted to a two-compartment open model and hydrochlorothiazide fitted to a one-compartment open model. Hydrochlorothiazide in vivo kinetic process in rats was in accordance with the linear dynamics. The combination of hydrochlorothiazide and rhynchophylla with pueraria promoted the absorption, reduced the elimination rate and prolonged the action time of puerarin in vivo. Meanwhile, the combination also promoted the absorption rate and the bioavailability, prolonged the action time and the accumulation time of hydrochlorothiazide in vivo.
出处 《药学学报》 CAS CSCD 北大核心 2009年第9期1056-1060,共5页 Acta Pharmaceutica Sinica
基金 2008年湖北省高等学校优秀中青年团队计划项目(T200807)
关键词 葛根素 氢氯噻嗪 脉君安片 药动学 puerarin hydrochlorothiazide Maijunan tablet pharmacokinetics
  • 相关文献

参考文献12

二级参考文献108

共引文献203

同被引文献34

  • 1Liang Shuo Hu,Jacob George,Jian Hua Wang.Current concepts on the role of nitric oxide in portal hypertension[J].World Journal of Gastroenterology,2013,19(11):1707-1717. 被引量:18
  • 2郭宾,李川.药物与血浆蛋白结合的药理学基础及其研究进展[J].中国临床药理学与治疗学,2005,10(3):241-253. 被引量:53
  • 3HSU FL, LIU IM, KUO DH, et al. Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats[ J]. J Nat Prod, 2003,66(6) :788 -792.
  • 4FELDMAN JM. Glyburide:a second-generation sulfonylurea hy- poglycemic agent [ J ]. Pharmacotherapy, 1985,5 ( 2 ) :43 - 62.
  • 5MARCHETTI P,NAVALESI R. Pharmacokinetic-pharmacodyna- mic relationships of oral hypoglycaemic agents: an update [ J ]. Clin Pharmacokinet, 1989,16 ( 2 ) : 100 - 128.
  • 6LI N,DENG Y,WANG D,et al. Determination of glibenclamide and puerarin in rat plasma by UPLC-MSMS: application to their pharmacokinetic interaction study [ J ]. Talanta, 2013, 104: 109 - 115.
  • 7WANG QQ, LI XS, DAI SJ, et al. Quantification of puerarin in plasma by on-line solid-phase extraction column switching liquid chromatography-tandem mass spectrometry and its applications to a pharmacokinetic study [ J ]. J Chromatogr B, 2008,863 ( 1 ) : 55 -63.
  • 8SRIRANGAM P,VIDYA SJ. Modulation of the p-glycoproein-me- diated intestinal secretion of glibenclamide :in vitro and in vivo as- sessments[J]. J Young Pharm,2010,2( 4 ) :379 -383.
  • 9LIANG XL, ZHAO LJ, LIAO ZG,et all Transport properties of puerarin and effect of Radix Angelicae Dahuricae extract on the transport of puerarin in Caco-2 cell model[J]. J Ethnopharma- col,2012,144 ( 3 ) :677 - 682.
  • 10BOYD AE,AGUILAR-BRYAN L,NELSON DA. Molecular mech- anisms of action of glyburide on the beta cell[J]. Am J Med, 1990,89(2A) :S3 - S10.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部